Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients
Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients
This research study is being done to determine if Distance Reiki therapy offers a quality of
 life benefit, and improves immunity compared to patients receiving Sham Distance Reiki
 therapy or no additional Reiki intervention.
Reiki is a popular complementary medicine modality sought after by patients. This non-
 intrusive Japanese based therapy centers on the guiding of energy through a Reiki
 practitioner to the patient which facilitates innate healing by modulation of energy fields.
 Reiki is formally classified as biofield therapy by the National Center for Complementary and
 Alternative Medicine (NCCAM).

 Current research indicates that Reiki shows promise as a noninvasive healing tool for mind
 and body, particularly among patients with cancer. However, the data validating the
 effectiveness of Reiki integrated within a structured medical paradigm and the effect on
 cancer immunity remains unknown.

 Given the clear demand for Reiki among cancer patients but skepticism within the medical
 community, this trial will aim to determine an objective patient reported quality of life
 (PRQoL) benefit by utilizing validated tools, in order to effectively implement Reiki into
 traditional medical practice.

 Multiple myeloma patients are at high risk of serious illness from the COVID-19 virus during
 this pandemic, and so distance Reiki will be carried out via video conferencing platform.
Inclusion Criteria:

 -  Age ≥ 18 years

 -  Patients with Multiple Myeloma within 6 months of their Autologous Stem Cell
 Transplant

 -  English Speaking

 -  Computer and internet access with video conferencing availability

 Exclusion Criteria:

 -  Evidence of disease relapse at the post-transplant follow up visit

 -  Patient not returning to Mayo Clinic Rochester for subsequent post-transplant follow
 up